Lupin Ltd., India's third largest drug firm by sales, on Aug. 2, said that its Japanese arm Kyowa Pharmaceutical Industry Co. Ltd. is acquiring 21 long-listed products (off-patent branded medicines) from Shionogi & Co. Ltd. , for 15.4bn yen ($150m).
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Scrip for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?